Table 3.
Model | Biomarker (p value) | AIC | H-L test (p value) | AUC (95% CI) | NRI (p value) | IDI (p value) |
---|---|---|---|---|---|---|
Clinical model | – | 197.2 | 0.01 | 0.79 (0.70–0.89) | – | – |
Clinical + uNGAL | 0.0008 | 188.7 | 0.21 | 0.82 (0.73–0.91) | 0.38 (0.04) | 0.06 (0.04) |
Clinical + pNGAL | 0.052 | 195.5 | 0.01 | 0.81 (0.72–0.90)* | 0.42 (0.02) | 0.02 (0.28) |
Clinical + uCyC | 0.76 | 199.1 | 0.01 | 0.79 (0.70–0.89) | −0.25 (0.17) | 0.0004 (0.88) |
Clinical + pCyC | 0.006 | 191.3 | 0.02 | 0.81 (0.72–0.90) | 0.08 (0.67) | 0.04 (0.09) |
H-L = Hosmer-Lemeshow.
p < 0.05 for improvement in AUC vs. clinical model alone.